Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial

Autor: O'Connor, Jemma, Vjecha, Michael J, Phillips, Andrew N, Angus, Brian, Cooper, David, Grinsztejn, Beatriz, Lopardo, Gustavo, Das, Satyajit, Wood, Robin, Wilkin, Aimee, Klinker, Hartwig, Kantipong, Pacharee, Klingman, Karin L, Jilich, David, Herieka, Elbushra, Denning, Eileen, Abubakar, Ibrahim, Gordin, Fred, Lundgren, Jens D

Publikováno v: O'Connor, J, Vjecha, M J, Phillips, A N, Angus, B, Cooper, D, Grinsztejn, B, Lopardo, G, Das, S, Wood, R, Wilkin, A, Klinker, H, Kantipong, P, Klingman, K L, Jilich, D, Herieka, E, Denning, E, Abubakar, I, Gordin, F, Lundgren, J D & INSIGHT START Study Group 2017, ' Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL : secondary outcome results from a randomised controlled trial ', The Lancet HIV, vol. 4, no. 3, pp. e105-e112 . https://doi.org/10.1016/S2352-3018(16)30216-8

BACKGROUND: The effects of antiretroviral therapy on risk of severe bacterial infections in people with high CD4 cell counts have not been well described. In this study, we aimed to quantify the effects of immediate versus deferred ART on the risk of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2d8d04950a722d3ba159a12bf2ec4f1d

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo

Autor: Sara K. Nissen, Giuseppe Pantaleo, Maja A. Sommerfelt, Mariane H. Schleimann, Rikke Olesen, Anne Sofie Høgh Kølbæk Kjær, Christel R. Brinkmann, Kim Krogsgaard, Kersten K. Koelsch, William J. Hey-Cunningham, Paul W. Denton, Ole S. Søgaard, Nicolas Chomont, Rémi Fromentin, Mette E. Graversen, Steffen Leth, Martin Tolstrup, Thomas A Rasmussen, Lars Østergaard

Publikováno v: Plos Pathogens, vol. 11, no. 9, pp. e1005142
Søgaard, O S, Graversen, M E, Leth, S, Olesen, R, Brinkmann, C R, Nissen, S K, Kjaer, A S, Schleimann, M H, Denton, P W, Hey-Cunningham, W J, Koelsch, K K, Pantaleo, G, Krogsgaard, K, Sommerfelt, M, Fromentin, R, Chomont, N, Rasmussen, T A, Østergaard, L J & Tolstrup, M 2015, ' The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo ', P L o S Pathogens, vol. 11, no. 9, e1005142, pp. 1-22 . https://doi.org/10.1371/journal.ppat.1005142
PLoS Pathogens, Vol 11, Iss 9, p e1005142 (2015)

UnlabelledPharmacologically-induced activation of replication competent proviruses from latency in the presence of antiretroviral treatment (ART) has been proposed as a step towards curing HIV-1 infection. However, until now, approaches to reverse HI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90ff5e3d2ca27a7ecdd7ba1489504abe
https://pubmed.ncbi.nlm.nih.gov/26645606

A Prospective Study of Efficacy and Safety of Once-Daily Saquinavir/Ritonavir plus Two Nucleoside Reverse Transcriptase Inhibitors in Treatment-Naive Thai Patients

Autor: Somboon Tansuphasawadikul, David A. Cooper, Umaporn Siangphoe, Phitsanu Raksakulkarn, Kiat Ruxrungtham, Andrew F. Hill, Warangkana Munsakul, Sasisopin Kiertiburanakul, Ploenchan Chetchotisakd, Reto Nüesch, Wisit Prasithsirikul, Bernard Hirschel, Jintanat Ananworanich

Publikováno v: Scopus-Elsevier
Antiviral Therapy, Vol. 10, No 6 (2005) pp. 761-767

ObjectiveTo assess the efficacy and safety of first-line treatment with once-daily saquinavir/ritonavir with two nucleoside reverse transcriptase inhibitors (NRTIs), as induction therapy before enrollment in a randomized trial of structured treatment

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::becab3677e68c31cacbca2af440353cf
https://doi.org/10.1177/135965350501000604

Resultados de um protocolo de atenção a gestantes portadoras do vírus da imunodeficiência humana em um serviço do nordeste do Brasil = Assessed results for a treatment protocol for HIV-positive pregnant women in northeastern Brazilian healt service

Autor: Pinho Neto, Otávio Soares, 1954

Publikováno v: Repositório Institucional da UnicampUniversidade Estadual de CampinasUNICAMP.

Orientador: Helaine Maria Besteti Pires Mayer Milanez
Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas
Made available in DSpace on 2018-08-26T14:20:51Z (GMT). No. of bitstreams: 1 PinhoNeto_OtavioSoares_

Externí odkaz: http://repositorio.unicamp.br/jspui/handle/REPOSIP/312689

Ageing with HIV: medication use and risk for potential drug-drug interactions

Autor: Marzolini, Catia, Back, David, Weber, Rainer, Furrer, Hansjakob, Cavassini, Matthias, Calmy, Alexandra, Vernazza, Pietro, Bernasconi, Enos, Khoo, Saye, Battegay, Manuel, Elzi, Luigia, Swiss HIV Cohort Study, Members

Publikováno v: Marzolini, Catia; Back, David; Weber, Rainer; Furrer, Hansjakob; Cavassini, Matthias; Calmy, Alexandra; Vernazza, Pietro; Bernasconi, Enos; Khoo, Saye; Battegay, Manuel; Elzi, Luigia; Swiss HIV Cohort Study, Members (2011). Ageing with HIV: medication use and risk for potential drug-drug interactions. Journal of antimicrobial chemotherapy, 66(9), pp. 2107-11. Oxford: Oxford University Press 10.1093/jac/dkr248
Journal of Antimicrobial Chemotherapy, vol. 66, no. 9, pp. 2107-2111

OBJECTIVES: To compare the use of co-medication, the potential drug-drug interactions (PDDIs) and the effect on antiretroviral therapy (ART) tolerability and efficacy in HIV-infected individuals according to age, ≥ 50 years or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b500f48e632b9891bf62c4caeb11690
https://boris.unibe.ch/8254/1/dkr248.pdf